Medical Industry Innovation Institute

Open Course 2017

Medical Industry Innovation Forum

The 2017 forum is over.

[Theme] Will multidisciplinary collaboration lead the way to new medical solutions?


October 14th, 2017 – March 20th ,2018 (7 sessions)
18:00 – 20:00 (*Nov.21th and Jan.30th 18:00-21:00) (A reception will be held after each lecture)


Tetsumon Memorial Hall
(14th Floor, Faculty of Medicine Experimental Research Building)

Target Audience
200 people
  • Undergraduate and graduate students (from The University of Tokyo and other universities)
  • Medical Innovation Industry Institute members
  • Healthcare professionals from medical institutes, academic societies, industries including pharmaceutical and medical device companies
  • Other professionals with a strong interest in leading Innovation in the medical industry
Registration Fee
Please pay the fee via a single bank transfer payment. We will provide the account information at a later date
  • Regular: 35,000JPY
  • Mi3 Member: 17,000JPY (It costs extra, annual membership fee 12,000 yen)
  • Student: Free, for 7 lectures. (Working students, please register in general)
Course Description

Lately, in the field of life science healthcare, not only is there an increase in the collaboration between medicine, engineering, and pharmacology, but also an increase in cooperation across the industrial, academic, and government sectors.
More and more, the evolving synergies between ICT, IoT, big data, and AI has expanded the future possibilities in the industry.
Meanwhile, the demand for medical innovations is ever increasing; not only to extend healthy living (QOL), but also to improve healthcare financing programs.
This year’s forum will discuss the latest trends in co-creation ( networking and diversified collaboration) within the life science and healthcare fields, as well as the ways to break through the barriers hindering the implementation of innovations, to the benefit of society.

Contact Information

Forum office within Medical Innovation Industry Institute
Tel: +81-3-5842-3363
Presented by Pharmaco-Business Innovation, Graduate School of Pharmaceutical Sciences, the University of Tokyo (Professor: Hiromichi Kimura).
The Forum is sponsored by the Medical Innovation Industry Institute

Hiromichi Kimura

The University of Tokyo
Visiting Professor

Koji Tamada

Department of Immunology, Yamaguchi University Graduate School of Medicine

Naoto Kondo

President and CEO

Haruhiko Hakuno

Health, Ministry of Health, Labour and Welfare

Osamu Nureki

Department of Biological Sciences, Graduate School of Science,The University of Tokyo

Yutaka Hanazono

Development of Advanced Medical Technology, Jichi Medical University
Director and Professor

Nov. 21st(Tue)”Special”
Kazuya Onomichi

Ajinomoto Co., INC.
Corporate Vice President

Yoshiyuki Tanaka

Du Pont Kabushiki Kaisha

Takashi Matsumoto

Compass to Healthy Life Research Complex Program, RIKEN
Group Director
(NineSigma Japan, Inc. Vice President)


Advantage Risk Management Co.,Ltd

Tsutahiro Hamaguchi

University of Occupational and Environmental Health part-time Professor
Firm & Brain co. Executive Director

Seiji Nishino

Psychiatry and Behavioral Sciences, Stanford University School of Medicine Professor
Sleep & Circadian Neurobiology Laboratory Director

Toshihiko Takeda

Health, Ministry of Health, Labour and Welfare

Masaya Watanabe

Healthcare Business Unit, Hitachi, Ltd.
Vice President and Executive Officer, CEO

Kiyohito Nakai

Director, Medical Device Evaluation Division
Pharmaceutical Safety and Environmental Health Bureau
Ministry of Health, Labor and Welfare

Jan. 30th(Tue)
Hiromichi Kimura

The University of Tokyo
Visiting Professor

Maki Sugimoto

Graduate School, International University of Health and Welfare
Associate Professor
HoloEyes Inc. Founder, COO

Yutaka Matsuo

Graduate School of Engineering, The University of Tokyo
Project Associate Professor

Kenji Kawachi

NewHeart Watanabe Institute

Yasuhiro Suzuki

Health, Ministry of Health, Labour and Welfare
Chief Medical & Global Health Officer, Vice-Minister

Greg Behar

Nestle Health Science CEO

Tadaatsu Hanadate

Corporate Planning, Astellas Pharma Inc.
Senior Manager

Hiroshi Kiyono, D.D.S., Ph.D.

Professor and Director,
Division of Mucosal Immunology,Department of Microbiology and Immunology,The Institute of Medical Science, The University of Tokyo

Director and Professor,
International Research & Development Center for Mucosal Vaccines,The Institute of Medical Science, The University of Tokyo

Mar.27th(Tue) “Special”
Nobuhiko Okabe

Director General
Kawasaki City Institute for Public Health

Tetsuo Nakayama

Project Professor
Kitasato Institute for Life Sciences

Chikara Kikuchi

Sr. Director, Japan Regulatory Affairs, Development Japan, Pfizer Japan Inc.

Ryosuke Tsuchiya

Former Chair Person, Kanagawa Prefectural Hospital Organization

Yumiko Mochizuki

Associate Director for Tobacco Free Japan and Business Development
Japan Cancer Society

Tetsuro Ishii

Vice President,
Corporate and Regulatory Affairs Division, Tobacco Business Headquarters, Japan Tobacco Inc.

Kyoko Murakami

Cooperate Affairs
Health outcome research RRP Manager
Philip Morris Japan LTD